Search Results

VIDAS Troponin I Assay is an automated quantitative test for use on the VIDAS instruments for the determination of human cardiac troponin 1 in serum or plasma (lithium heparinate) using the ELFA (Enzyme-Linked Fluorescent Assay) technique

The VIDAS Troponin I (TNI) Assay is an enzyme-linked fluorescent immunoassay (ELFA) performed in an automated VIDAS® instrument. All assay steps and assay temperature are controlled by the instrument. A pipette tip-like disposable device, the Solid Phase Receptacle (SPR), serves as the solid phase as well as a pipettor for the assay. Reagents for the assay are in the sealed TNI Reagent Strips.

The sample is transferred into the wells containing anti-cardiac troponin I antibodies labeled with alkaline phosphatase (conjugate). The sample/conjugate mixture is cycled in and out of the SPR for a specified length of time. Troponin I present in the specimen will bind to the anti-cardiac troponin I immunoglobulin coating the interior of the SPR. Unbound sample components are washed away.

A fluorescent substrate, 4-methylumbelliferyl phosphate, is introduced into the SPR. Enzyme remaining on the SPR wall will catalyze the conversion of the substrate to the fluorescent product 4-methylumbelliferone. The optical scanner in the instrument measures the intensity of fluorescence. When the VIDAS TNI assay is completed, the results are analyzed automatically by the computer, a test value is generated, and a report is printed for each sample.

Here's a breakdown of the acceptance criteria and study details for the VIDAS Troponin I (TNI) Assay, based on the provided text:

1. Table of Acceptance Criteria and Reported Device Performance:

The document doesn't explicitly state "acceptance criteria" as a separate, pre-defined column. Instead, it presents performance data for both the VIDAS TNI assay and its predicate device, the Stratus CS Cardiac Troponin I Testpak, implying that the VIDAS TNI assay needed to demonstrate comparable performance to the predicate. The "Reported Device Performance" column reflects the performance of the VIDAS TNI assay.

2. Sample Size Used for the Test Set and Data Provenance:

• Plasma samples: 107 samples.
• Serum samples: 32 samples.
• Provenance: Not explicitly stated. The document refers to "apparently healthy patients" and "clinically healthy patients" for expected values, but no geographical origin or retrospective/prospective nature is specified for the clinical correlation studies. This suggests that these samples were likely collected for the purpose of the study.

3. Number of Experts Used to Establish Ground Truth for the Test Set and Qualifications of Those Experts:

Not applicable. This is an in vitro diagnostic (IVD) device for quantitative measurement of a biomarker. The "ground truth" for the test set is established by the values obtained from the predicate device (SCS Cardiac Troponin I) and direct analytical measurements (e.g., for precision, sensitivity, interference). Expert judgment in the way it's used for image-based diagnostics with human interpretation is not relevant here.

4. Adjudication Method for the Test Set:

Not applicable. As noted above, this is an IVD device. The comparison is between the quantitative results of the new device and the predicate device.

5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:

Not applicable. This is an IVD test, not an AI-assisted diagnostic device that involves human readers interpreting results.

6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) was done:

The device itself is an automated instrument performing an Enzyme-Linked Fluorescent Immunoassay (ELFA). Its performance is inherently "standalone" in the sense that the instrument performs all assay steps and analysis automatically, generating a test value for each sample. There is no human-in-the-loop interpretation or intervention in the generation of the quantitative result.

7. The Type of Ground Truth Used:

• Clinical Testing (Correlation): The "ground truth" for the clinical correlation studies was the result obtained from the predicate device, the Stratus CS Cardiac Troponin I Testpak. The study compared the VIDAS TNI results directly to those of the predicate.
• Nonclinical Testing (Analytical Performance): For analytical performance characteristics like precision, sensitivity, dilution recovery, and interference, the ground truth is established through controlled laboratory experiments and reference materials/methods (e.g., known concentrations for sensitivity and recovery, spiked samples for interference). For "Expected Values," the ground truth was observational data from a cohort of apparently/clinically healthy individuals.

8. The Sample Size for the Training Set:

Not explicitly stated. This document describes a 510(k) submission, which focuses on demonstrating substantial equivalence, primarily through verification and validation testing, rather than explicit "training set" size for a machine learning model. For an IVD device like this, the development likely involved:

• Pre-clinical testing to optimize reagents and assay parameters (which could be considered analogous to training/optimization).
• Clinical validation studies for the 510(k) submission.

The reported sample sizes (107 plasma, 32 serum, 496 healthy patients, 101 healthy patients) are those used for the validation/test phase presented in the submission.

9. How the Ground Truth for the Training Set Was Established:

Not explicitly stated. Given that this is an immunoassay, the "training" phase would involve traditional assay development and optimization (e.g., optimizing antibody concentrations, incubation times, wash steps) using characterized samples or reference materials. The "ground truth" during this development would be based on established analytical chemistry principles, known concentrations of analytes, and comparisons to existing reference methods or the performance targets of an already existing predicate device.

Ask a specific question about this device